Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:44 AM UTC
| NCT Number | NCT04768426 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stanford University |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 19, 2026: Clinical trial NCT04768426 is currently recruiting participants. This phase2 study for triple negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Stanford University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04768426 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04768426 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.